Macrocyclic inhibitors of flaviviridae viruses
US9873716B2 · kind B2 · utility
2Cited by
6References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 16, 2015 |
| Grant date | Jan 23, 2018 |
| Priority date | — |
| Expiry date | Jun 16, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are compounds of Formula I:and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.